Clinical trial
Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
NCT07927530 is registered in ClinicalTrials.gov with Hatice Zehra FERHATLAR as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
- Lead sponsor
- Hatice Zehra FERHATLAR
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 23, 2026
- Completion date
- April 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic low back pain, type 2 diabetes mellitus (dm)
Arms
As registered; 2 arms.
-
Thoracolumbar Fascia Injection Group
-
Standard Conservative Treatment Group
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in Low Back Pain Intensity Measured by the Numeric Rating Scale (NRS)
Lead sponsor's other trials
Hatice Zehra FERHATLAR, most recent start first.
Similar trials
Same condition (Diabetes Mellitus, Type 2) and phase, most recent start first.
+3,730 more trials See the condition page